Clinical Impact of Interstitial Lung Disease on Advanced Non-Small Cell Lung Cancer

被引：0
|
作者：
Oi, H. [1 ]
Taniguchi, H. [1 ]
Kondoh, Y. [1 ]
Kimura, T. [1 ]
Kataoka, K. [1 ]
Matsuda, T. [1 ]
Yokoyama, T. [1 ]
机构：
[1] Tosei Gen Hosp, Resp Med & Allergy, Seto, Japan
来源：
JOURNAL OF THORACIC ONCOLOGY | 2017年 / 12卷 / 11期
关键词：
Advanced Non-Small Cell Lung Cancer; interstitial lung disease;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P2.01-037
引用
收藏
页码：S2082 / S2082
页数：1
相关论文
共 50 条
  • [1] Chemotherapy for advanced non-small cell lung cancer with interstitial lung disease
    Ichihara, E.
    Takigawa, N.
    Hisamoto, A.
    Hotta, K.
    Tabata, M.
    Klura, K.
    Tanimoto, M.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [2] Pemetrexed for advanced non-small cell lung cancer patients with interstitial lung disease
    Kato M.
    Shukuya T.
    Takahashi F.
    Mori K.
    Suina K.
    Asao T.
    Kanemaru R.
    Honma Y.
    Muraki K.
    Sugano K.
    Shibayama R.
    Koyama R.
    Shimada N.
    Takahashi K.
    [J]. BMC Cancer, 14 (1)
  • [3] Impact of Interstitial Lung Disease on Survival for Patients with Non-small Cell Lung Cancer
    Miyazaki, Kunihiko
    Satoh, Hiroaki
    Kurishima, Koichi
    Nakamura, Ryota
    Ishikawa, Hiroichi
    Kagohashi, Katsunori
    Ohara, Gen
    Hizawa, Nobuyuki
    [J]. ANTICANCER RESEARCH, 2009, 29 (07) : 2671 - 2674
  • [4] Interstitial Lung Disease Associated with Docetaxel in Patients with Advanced Non-small Cell Lung Cancer
    Tamiya, Akihiro
    Naito, Tateaki
    Miura, Satoru
    Morii, Sakae
    Tsuya, Asuka
    Nakamura, Yukiko
    Kaira, Kyoichi
    Murakami, Haruyasu
    Takahashi, Toshiaki
    Yamamoto, Nobuyuki
    Endo, Masahiro
    [J]. ANTICANCER RESEARCH, 2012, 32 (03) : 1103 - 1106
  • [5] Impact of Coexisting Interstitial Lung Disease on Resected Non-Small Cell Lung Cancer Patients
    Lee, J. G.
    Park, S. Y.
    Lee, C. Y.
    Narm, K. S.
    Song, S. H.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S253 - S253
  • [6] A nomogram for the prediction of the survival of patients with advanced non-small cell lung cancer and interstitial lung disease
    Xiu, Weigang
    Zheng, Jincheng
    Zhou, Yuwen
    Du, He
    Li, Jiayu
    Li, Wei
    Zhou, Fei
    Zhou, Caicun
    Wu, Fengying
    [J]. CANCER MEDICINE, 2023, 12 (10): : 11375 - 11384
  • [7] Pemetrexed Plus Platinum for Patients With Advanced Non-small Cell Lung Cancer and Interstitial Lung Disease
    Fujita, Tetsuo
    Kuroki, Tsuguko
    Hayama, Nami
    Shiraishi, Yuka
    Amano, Hiroyuki
    Nakamura, Makoto
    Hirano, Satoshi
    Tabeta, Hiroshi
    Nakamura, Sukeyuki
    [J]. IN VIVO, 2019, 33 (06): : 2059 - 2064
  • [8] Fatal interstitial lung disease after erlotinib for non-small cell lung cancer
    Lind, Joline S. W.
    Smit, Egbert F.
    Grunberg, Katrien
    Senan, Suresh
    Lagerwaard, Frank. J.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2008, 3 (09) : 1050 - 1053
  • [9] Atezolizumab and nintedanib in patients with non-small cell lung cancer and interstitial lung disease
    Yamaguchi, Teppei
    Shimizu, Junichi
    Shigematsu, Fumie
    Watanabe, Naohiro
    Hasegawa, Takaaki
    Horio, Yoshitsugu
    Inaba, Yoshitaka
    Fujiwara, Yutaka
    [J]. JOURNAL OF THORACIC DISEASE, 2024, 16 (05) : 3371 - 3380
  • [10] T cell immunity in interstitial lung disease with non-small cell lung cancer patients
    Isono, Tomomi
    Iwahori, Kota
    Yanagawa, Masahiro
    Yamamoto, Yoko
    Tone, Mari
    Haruna, Miya
    Hirata, Michinari
    Fukui, Eriko
    Kimura, Toru
    Kanou, Takashi
    Ose, Naoko
    Funaki, Soichiro
    Takeda, Yoshito
    Morii, Eiichi
    Kumanogoh, Atsushi
    Shintani, Yasushi
    Wada, Hisashi
    [J]. LUNG CANCER, 2023, 182
12345